Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia. (Q33497104)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia. |
scientific article |
Statements
Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia (English)
Beran M
Kantarjian H
O'Brien S
Koller C
al-Bitar M
Arbuck S
Pierce S
Moore M
Abbruzzese JL
Andreeff M
Keating M